FI53314C - Foerfarande foer framstaellning av farmaceutiskt anvaendbar 2-(fenyleller p-klorfenyl) oxazol-4-yl (aettiksyra -acetatsalt eller -acetamid) - Google Patents

Foerfarande foer framstaellning av farmaceutiskt anvaendbar 2-(fenyleller p-klorfenyl) oxazol-4-yl (aettiksyra -acetatsalt eller -acetamid)

Info

Publication number
FI53314C
FI53314C FI964/68A FI96468A FI53314C FI 53314 C FI53314 C FI 53314C FI 964/68 A FI964/68 A FI 964/68A FI 96468 A FI96468 A FI 96468A FI 53314 C FI53314 C FI 53314C
Authority
FI
Finland
Prior art keywords
phenyleller
anvaendbar
chlorphenyl
oxazol
pharmaceuticals
Prior art date
Application number
FI964/68A
Other languages
English (en)
Other versions
FI53314B (fi
Inventor
Kevan Brown
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Application granted granted Critical
Publication of FI53314B publication Critical patent/FI53314B/fi
Publication of FI53314C publication Critical patent/FI53314C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
FI964/68A 1967-06-14 1968-04-08 Foerfarande foer framstaellning av farmaceutiskt anvaendbar 2-(fenyleller p-klorfenyl) oxazol-4-yl (aettiksyra -acetatsalt eller -acetamid) FI53314C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2738267 1967-06-14

Publications (2)

Publication Number Publication Date
FI53314B FI53314B (fi) 1977-12-30
FI53314C true FI53314C (fi) 1978-04-10

Family

ID=10258701

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964/68A FI53314C (fi) 1967-06-14 1968-04-08 Foerfarande foer framstaellning av farmaceutiskt anvaendbar 2-(fenyleller p-klorfenyl) oxazol-4-yl (aettiksyra -acetatsalt eller -acetamid)

Country Status (3)

Country Link
US (1) US3574228A (fi)
FI (1) FI53314C (fi)
YU (1) YU34086B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2844394A1 (de) * 1978-10-12 1980-04-30 Hoechst Ag Neue 4-chloroxazole und verfahren zu deren herstellung
US4303439A (en) * 1979-10-01 1981-12-01 Monsanto Company 2-Substituted-4-alkyl or trihaloalkyl-5-oxazolecarboxylic acids as safening agents
JPS57188587A (en) * 1981-05-15 1982-11-19 Tanabe Seiyaku Co Ltd Thienyloxazolylacetic acid derivative and its preparation
JPS58148882A (ja) * 1982-02-26 1983-09-05 Tanabe Seiyaku Co Ltd フリルオキサゾリル酢酸誘導体及びその製法
JPS58201771A (ja) * 1982-05-19 1983-11-24 Tanabe Seiyaku Co Ltd アルキルオキサゾリル酢酸誘導体
JPS58219169A (ja) * 1982-06-15 1983-12-20 Takeda Chem Ind Ltd オキサゾ−ル酢酸誘導体
US5239080A (en) * 1989-02-08 1993-08-24 Takeda Chemical Industries, Ltd. Oxazole compounds and their use as antidiabetic and bone-reduction inhibitory agents
EP0440183A1 (en) * 1990-02-01 1991-08-07 Takeda Chemical Industries, Ltd. Oxazole compounds, their production and use
FR2663331B1 (fr) * 1990-06-14 1994-05-06 Bellon Laboratoires Nouveaux derives de l'oxazole, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2699172B1 (fr) * 1992-12-11 1995-01-20 Adir Nouveaux dérivés de 4-méthyl-1,3-oxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
JP2636819B2 (ja) 1994-12-20 1997-07-30 日本たばこ産業株式会社 オキサゾール系複素環式芳香族化合物
MY128323A (en) * 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion
KR100863659B1 (ko) * 2001-04-16 2008-10-15 미쓰비시 타나베 파마 코퍼레이션 질소-함유 헤테로시클릭 화합물 및 이를 포함하는 제약 조성물

Also Published As

Publication number Publication date
YU133568A (en) 1978-06-30
FI53314B (fi) 1977-12-30
YU34086B (en) 1978-12-31
US3574228A (en) 1971-04-06

Similar Documents

Publication Publication Date Title
FI49497C (fi) Menetelmä terapeuttisesti vaikuttavien 1-fenoksi-2-3-alkyyliaminopropa anien valmistamiseksi.
SE382065B (sv) Forfarande for framstellning av linkomycinderivat
FI48727C (fi) Menetelmä asetyyliguanidiinien valmistamiseksi.
FI53314C (fi) Foerfarande foer framstaellning av farmaceutiskt anvaendbar 2-(fenyleller p-klorfenyl) oxazol-4-yl (aettiksyra -acetatsalt eller -acetamid)
FI55184C (fi) Foerfarande foer framstaellning av terapeutiskt verksamma fenyl-2-pyrrolidinoner samt deras isomerer
DK118820B (da) Analogifremgangsmåde til fremstilling af derivater af 5-nitro-2-furyl-isoxazoliner.
DK118344B (da) Fremgangsmåde til fremstilling af et terapeutisk aktivt decapeptid eller salte heraf.
DK125850B (da) Analogifremgangsmåde til fremstilling af heterocykliske forbindelser.
DK123868B (da) Analogifremgangsmåde til fremstilling af 3-hydroxycumarin-derivater.
AT297482B (de) Abbildungsverfahren
DK117501B (da) Fremgangsmåde til fremstilling af d-lysergsyre-alkanol-amider.
FI51175C (fi) Menetelmä terapeuttisesti käytettävien indanyylitiokarbamaattien valmi stamiseksi.
FI49496C (fi) Menetelmä terapeuttisesti vaikuttavien uusien substituoitujen raseemis ten tai optisesti aktiivisten 1-fenoksi-2-hydroksi-3-alkyyli-aminoprop aanien valmistamiseksi.
DK122274B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive naphthoxypropanolaminderivater eller salte heraf.
DK125321B (da) Analogifremgangsmåde til fremstilling af fluorholdige derivater af phenoxyisosmørsyre.
FR1423389A (fr) Transducteurs pour pyromètres à radiation
AT301340B (de) Abbildungsverfahren
DK119976B (da) Analogifremgangsmåde til fremstilling af 18-methyl-19-nor-17α-hydroxyprogesteroner og -17-estere deraf.
DK122076B (da) Analogifremgangsmåde til fremstilling af carbamater af hydroxymethylpyridinderivater.
FI45553C (fi) Menetelmä terapeuttisesti käytettävien 16-tiosubstituoitujen 9beta,10a lfa-pregneenien valmistamiseksi
DK135310B (da) Analogifremgangsmåde til fremstilling af 1-(2-ethinylphenoxy)-2-hydroxy-3-butylaminopropaner.
SE333149B (sv) Foerfarande foer framstaellning av bensimidazol-n-oxider
SE343302B (sv) Foerfarande foer framstaellning av bensomorfanderivat
FI48841C (fi) Menetelmä farmakologisesti aktiivisten 5-nitro-2-furfuryylideeniamino- oksatsolidinonien valmistamiseksi.
DK118285B (da) Fremgangsmåde til fremstilling af terapeutisk aktive piperidinderivater eller salte deraf.